Paper Details

  1. Home
  2. Paper Details

Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.

Author: BrigoFrancesco, CagnettiClaudia, Del GiovaneCinzia, LattanziSimona, SilvestriniMauro, TrinkaEugen, ZaccaraGaetano

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.

Overview

Cannabidiol (CBD), a non-psychoactive component of Cannabis sativa, shows promise as a new therapeutic option for epilepsy. CBD exhibits anti-seizure properties through multiple mechanisms, including modulation of ionic channels and neurotransmitter transporters.
Paper Details　
Original Abstract of the Article :
Approximately one-third of patients with epilepsy presents seizures despite adequate treatment. Hence, there is the need to search for new therapeutic options. Cannabidiol (CBD) is a major chemical component of the resin of Cannabis sativa plant, most commonly known as marijuana. The anti-seizure pr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1007/s40265-018-0992-5

データ提供：米国国立医学図書館（NLM）

Cannabidiol: A Potential New Treatment for Epilepsy

Epilepsy, a disorder characterized by recurrent seizures, is a challenging condition that can feel like navigating a desert of unpredictable brain activity. This study explores the potential of cannabidiol (CBD), a non-psychoactive component of the cannabis plant, as a new therapeutic option for epilepsy. The authors conducted a systematic review and meta-analysis of existing research on CBD's efficacy and safety in epilepsy. This comprehensive approach, like a carefully curated map of the desert, provides a thorough understanding of CBD's potential benefits and risks.

CBD Shows Promise for Epilepsy Treatment

The review and meta-analysis suggest that CBD holds promise as a potential treatment option for epilepsy, particularly for patients who experience seizures despite adequate treatment with traditional anti-seizure medications. The study suggests that CBD may be effective in reducing seizure frequency, offering a potential new avenue for managing this challenging condition.

Exploring New Frontiers in Epilepsy Management

This research highlights the potential of CBD as a promising new frontier in epilepsy treatment. By understanding the mechanisms of action of CBD, researchers can develop more targeted therapies and potentially improve the quality of life for individuals living with epilepsy.

Dr. Camel's Conclusion

This study offers a compelling glimpse into the potential of CBD to provide relief for individuals struggling with epilepsy. It's like discovering a hidden oasis in the desert of epilepsy treatment, offering a potential source of healing and improved quality of life.

Date :
  1. Date Completed 2019-07-31
  2. Date Revised 2019-07-31
Further Info :

Pubmed ID

30390221

DOI: Digital Object Identifier

10.1007/s40265-018-0992-5

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.